![CRISPR Therapeutics AG [CRSP] posts $650.18M loss as revenue falls 99.87% to $1.20M](/_next/image?url=http%3A%2F%2F10kinfo-appdata.s3.amazonaws.com%2Fedgar0105%2FCompanyLogos%2FUS%2FCRSP.png&w=3840&q=75)
CRISPR Therapeutics AG [CRSP] posts $650.18M loss as revenue falls 99.87% to $1.20M
By USInMinutes
Published - Feb 22, 2023, 02:35 AM ET
Last Updated - Mar 06, 2023, 02:36 PM EST
| Net Sales: | $1.20M |
CRISPR Therapeutics AG [CRSP] posted a loss of $650.18M, marking a fall of 272.16% for this year.
Revenue fell to $1.20M this year compared to $914.96M in the previous year.
According to the latest annual report the company has filed with the SEC, current earnings were $-650.18M, down 272.16% from $377.66M.
The company’s net sales for the period were $1.20M, down 99.87%. Net sales in the previous year were $914.96M.
